B
one regenerative procedures can be performed using a wide variety of techniques and grafting materials. Due to their high predictability, 1 these operations are employed in a multitude of different clinical scenarios. As widely described in the literature, extractions lead to dimensional changes in bone architecture, 2, 3 occurring mostly within the first 12 months. [2] [3] [4] [5] [6] Overall, the crestal width reduction can be greater than 50%, with two-thirds of this horizontal resorption occurring during the first 3 months after extraction. 2, [4] [5] [6] Due to these volumetric changes, different approaches have been proposed, including but not limited to: guided bone regeneration (GBR), 7 block grafting techniques, 8 ridge split, 9 and also the use of narrow-diameter implants. 10 Nevertheless, to achieve an adequate tridimensional position of standard-diameter implants, 10 these horizontally compromised ridges require bone augmentation procedures.
As a result, different classification systems have been developed proposing several horizontal augmentation techniques based on the remaining alveolar process. 8 Nonetheless, predictable regenerative procedures can often be successfully accomplished by a variety of different approaches depending mostly on operator skills and flap management rather than the specific technique utilized. Similarly, several bone grafting materials have been described based on their origin; namely, autografts (AGs) derive from the individual's own body, allografts (ALLs) derive from another individual of the same species, xenografts (XEs) derive from a different species, and alloplasts (ALPs) derive from synthetic materials.
In the case of bone dehiscence and/or fenestrations during implant insertion, the success of deproteinized bovine bone mineral (DBBM) or AG particulate in conjunction with membranes has been widely reported.
On the other hand, in the case of horizontal augmentation, autologous bone blocks have been claimed to offer the best results. 7 In a systematic review, Milinkovic and Cordaro described a 3.31-mm gain when using GBR versus a 4.3-mm gain when using bone blocks for horizontal defects. 8 On the other hand, more recent investigations have proven GBR techniques to be the most reliable in terms of bone gain and absence of complications. As such, Urban and colleagues demonstrated vertical bone gain of 5.1 ± 1.8 mm and horizontal bone gain of 7.0 ± 1.5 mm by means of combination of XE and AG with barrier membranes. [11] [12] [13] While bone regeneration has been widely proved to be a predictable procedure, 14, 15 its shortand long-term volumetric stability remains to be further investigated. Prosthetically driven implant positioning is of paramount importance for optimal treatment outcomes 16 ; however, the peripheral bone stability over time also represents a key factor for long-term success. 17 Despite the vast amount of literature reporting data on horizontal bone gain, 1, 7, 8 the stability of bone regenerative procedures over time remains poorly studied. Hence, it is the objective of the present review to report the current evidence on horizontal grafting technique stability over time.
MATERIALS AND METHODS

Information Sources
An electronic literature search was conducted by two independent reviewers (B.E. and C.P.) in several databases, including MEDLINE, Embase, the Cochrane 
Eligibility Criteria
Articles that met the following inclusion criteria were included in this systematic review: prospective randomized trials involving human subjects that analyzed clinical outcomes of horizontal bone augmentation. Accordingly, several factors such as study design, number of patients included in the last follow-up assessment, number of defect sites, smoking or other systemic conditions that might alter the outcome, and type of procedure (including whether bone grafting material or barrier membranes were used) were extracted from the selected studies and analyzed (Table 1) . On the other hand, nonrandomized studies, retrospective and in vitro investigations, studies failing to report horizontal bone augmentation, case reports or case series with less than five subjects, systematic reviews, preclinical animal studies, and human trials not studying any of the aforementioned regenerative therapies were excluded. Human trials with missing information were also excluded.
Risk of Bias
Two reviewers (B.E. and C.P.) designed and assessed the proposal for the present project to make sure that the STROBE statement and PRISMA guidelines were followed. STROBE stands for an international, collaborative initiative of epidemiologists, methodologists, statisticians, researchers, and journal editors involved in the conduction and dissemination of observational studies, and consists of a 22-item checklist to be fulfilled in a systematic review.
Qualitative Assessment
The quality of the selected randomized controlled trials 
Statistical Analysis
The R 3.0.2 software package was used to perform the meta-analysis. The primary variables were: initial bone gain (mm), final bone gain (mm), and resorption (mm). The secondary variable was implant survival. The analysis was performed using the methodology described below. When bone change values were missing relative standard deviation, an estimate was made from the linear correlation between the initial and final bone gain. Graft resorption data showed high heterogeneity, due to the variability in the measurement units (mm versus %). Mean millimeter values were selected for analysis. Bone gain and resorption were analyzed as subject units, while implant survival rates were analyzed as implant units. Furthermore, meta-regression models with the moderator variable being the technique used (block or GBR) and type of biomaterial (ALL, AG, ALP) were estimated likewise under the random effects approach. This analysis would afford an aggregate estimate of major responses and conclude whether there were differences in the moderator variable. Calculations were based on the inverse variance method of DerSimonian and Laird. Resorption value units differed among authors. The absolute value was recorded in mm, cm 3 , and as percentages. Volumetric and percentage values were discarded, the latter being computed as absolute values directly from the difference between the baseline and final bone gain. The meta-analysis consisted of an estimation of total graft resorption upon healing and, hence, final regenerated bone gain as well as survival for all the studies based on the mean value based on a random effects model.
Study of Heterogeneity
Heterogeneity was assessed based on calculation of the I 2 statistic (percentage variability of estimated effect that can be attributed to the heterogeneity of the effects) and the null statistic test. Galbraith graphs displayed the degree of heterogeneity. In studies where great heterogeneity was detected, a sensitivity analysis was performed to determine its source. Funnel plots and the Egger test were used to assess risk of bias; the accepted statistical significance level was 5% (P = .05).
RESULTS
Study Screening
The initial manual and electronic search resulted in a total of 2,879 publications, 750 of which were selected after evaluation of titles and abstracts. Thirtyfive full-text investigations were further evaluated.
Of these, 17 fulfilled the inclusion criteria [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [33] [34] [35] [36] [37] (Fig 1) . Details of the excluded articles are provided in Table 2 .
Study Quality
All the articles selected were RCTs. The randomized clinical trial checklist of the Cochrane Center and CON-SORT (Consolidated Standards of Reporting Trials) statement was used to score study quality. The degree of bias was categorized as low risk if all the criteria were met, moderate risk when only one criterion was missing, and high risk if two or more criteria were missing. 18, 19 Low (45%) to moderate (65%) estimated potential risk of bias was found from the studies included in the qualitative appraisal.
Intergroup Meta-analysis A thorough literature review was made, leading to a final selection of 17 studies, all of which were RCTs. Therefore, the design allowed the comparison of results between a test group and a control group. Fifteen of these articles provided information on number of implants employed. 1, [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [34] [35] [36] [37] Three studies 26, 31, 32 did not mention the number of implants, and therefore had to be excluded from the numerical analysis. The 15 eligible articles were divided into 31 independent studies (separating test and control groups), with a total of 772 implants. The mean follow-up for implants was 11.9 ± 7.8 months.
Initial Bone Gain
A total of eight studies 20, 22, [28] [29] [30] 33, 35, 36 reported information on initial bone gain, which led to a total sample of 310 implants. The measures of mean gain given by the different studies ranged from 2.10 mm in the GBR group as reported by de Freitas et al 30 to 4.56 mm in the bone block group in the study by Cordaro et al. 28 For all techniques combined, the estimated mean (± SD) initial bone gain was 3.71 ± 0.24 mm (Fig 2a) . The 95% confidence interval (95% CI) for this mean gain was [3.24 to 4.19] . The above measures and their graphic synthesis also revealed important heterogeneity: I 2 = 0.959 (95.9% of total variability). The Cochran heterogeneity test confirmed statistical significance (P < .001). Discrepancy was noted among some studies in terms of bone volume gain measurement.
Final Bone Gain
A total of 13 studies 20, [22] [23] [24] [25] [27] [28] [29] [30] [33] [34] [35] [36] reported information on final bone gain after 4 to 8 months. With regard to the implants, there was a mean time for re-evaluation of 6 months with a range of 11.9 ± 7.8 months. These investigations led to a total sample of 703 implants. The measures of mean gain given by the different studies ranged from 0.65 mm (Annen et al 22 ) to 5.08 mm (Castagna et al 27 ) . It should be noted that all studies except the one from Annen et al 22 concluded with non-null final bone gain. The estimated final mean gain (± SD) was 2.86 ± 0.23 mm (Fig 2b) . The 95% confidence interval (CI) for this mean gain was [2.40 to 3.32] . This was interpreted in the usual way; ie, with a 95% confidence interval, the true mean value of the final gain in the sample would be between these two values. The final gain for blocks was 4.03 ± 0.49 mm, CI [3.06, 5 .00]; while the final bone gain for GBR was 2.59 ± 0.23 mm, CI [2.13, 3.06]. There was not a significant difference with regard to different techniques and resorption rates (P = .412). However, with block grafting procedures, the resorption can be considered almost null (P = .193); while with GBR it was significantly nonnull (P < .001). Therefore, a non-null gain was concluded (P < .001). The Egger test accepted symmetry (P = .423). In other words, studies with low relative weight (due to small sample size or high variability), resulted in dispersed gain values.
Biomaterial Effect
The mean bone gain of the 13 studies 20, [22] [23] [24] [25] [27] [28] [29] [30] [33] [34] [35] [36] using different biomaterials was compared: AG, AG+XE, ALP, and XE (group N of de Freitas et al 30 (Fig 2c) .
For the mean initial bone gain in eight studies, 20, 22, [28] [29] [30] 33, [35] [36] six studies using GBR 20, 22, 30, 33, 35, 36 were compared with two studies using the block graft technique. 28, 29 The estimated measures were: 4.03 ± 0.49 mm, CI [3.06 to 5.00] (P < .001) for block grafting and 2.59 ± 0.23 mm, CI [2.13 to 3.06] (P < .001) for GBR. The final mean gain in all the groups proved positive (significantly non-null) for GBR. There were statistically significant differences in the bone gain achieved with one technique or the other (P = .009). This observation was taken to indicate that the block technique is superior to the GBR technique.
Resorption
Resorption was defined as the difference between the initial postsurgical site increase and the residual gain after healing 4 to 8 months later. This parameter was regarded as the main outcome of the investigation. A total of nine studies reported information on resorption, 22, 23, [28] [29] [30] 33, [35] [36] [37] which led to a total sample of 304 implants. The estimated mean resorption (± SD) was 1.17 ± 0.23 mm (Fig 2d) . The 95% confidence interval for this measure was [0.73 to 1.62]. This was interpreted in the usual way; ie, with a 95% confidence interval, the true mean value of resorption in the sample would be between 0.73 and 1.62 mm. Hence, it could be admitted that there is non-null resorption (P < .001). It can be visually observed that for the final estimation (RE random effects model), the confidence interval excludes zero. The heterogeneity between studies was 95.4% of the total variability (between studies + within studies), implying I 2 = 0.954. The result of the Cochran heterogeneity test confirmed the importance of this value (P < .001). The shape of the funnel plot is slightly different than usual. For example, in the middle right part of the cone, some studies show a small sample and/or high standard deviation (high standard error). These studies report high positive resorption. The Egger test reflected this general asymmetry (P = .136) without reaching statistical significance.
Technique Effect
Resorption values, deriving from eight studies using the GBR technique, 22, 23, 29, 30, 33, [35] [36] [37] were compared with those reported in two studies 20, 28 using the block technique. The estimated measures were: 0. (Fig  2e) . The differences in resorption were not statistically significant between techniques (P = .412). However, an important observation is that with the block graft technique, resorption can be considered almost zero (the interval includes zero; P = .193), while resorption with the GBR technique is significantly non-null (P < .001).
Survival
A total of 13 studies [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [33] [34] [35] [36] [37] reported information on final bone gain, which led to a total sample of 725 implants. The rates among different investigations were practically invariable: all reported a survival rate of 100%, except for the study performed by Castagna and colleagues, in which bone blocks were performed along with immediate implant placement and loading, 27 where the survival rate was 98.9%. Also, the study published by Mordenfeld et al 35 reported a survival rate of 97%. The weighted survival rate was 99.9%, with a 95% confidence interval of [99.6 to 100] (Fig 2f ) .
DISCUSSION
Since the early 1980s, when Dahlin et al 14 applied the principles of cellular exclusion with bone regeneration for augmentation of the bone crest, many studies have reported success with the regeneration of horizontal defects. [38] [39] [40] [41] The initial bone gain found in this systematic review was 3.71 ± 0.24 mm, with an estimated final gain of 2.86 ± 0.23 mm after 1 year. These findings are consistent with the results of previous studies in which a gain of 3.31 mm was reported. 10 Sanz-Sánchez et al 42 found that for the staged approach, the combination of bone blocks, particulated grafts, and barrier membranes provided the best outcomes, despite the potential morbidity and advent of postoperative complications. The maximum bone width gain was reported for the combination of particulate xenograft + autologous bone + absorbable membrane (weighted mean difference [WMD] = 5.68 mm; 95% CI: 5.00, 6.35; P < .001), whereas the minimum was for the combination of particulate synthetic graft + nonabsorbable membrane (WMD = 1.10 mm; 95% CI: -0.33, 2.53; P = .131). The lateral bone augmentation procedure using an autologous bone block alone was the most frequently used, demonstrating a significant width gain (WMD = 4.25 mm; 95% CI: 4.04, 4.47; P < .001). 42 The comparison between GBR and block graft techniques showed a mean greater initial bone gain after the second procedure (4.03 ± 0.49 mm). 20, 21, 27, 28, 31 This difference may have been influenced by the technique itself, since placing a xenograft and a membrane over the block graft could minimize bone resorption. 28 When the GBR technique was used, the mean bone gain was found to be 2.59 ± 0.23 mm 1, [22] [23] [24] [25] [26] 29, [33] [34] [35] [36] [37] (Fig  3) . In this group, the use of a titanium mesh showed the greatest gain 20,30 among other membranes.
The comparison of final bone gain based on the biomaterial used demonstrated the autologous bone as the one providing the greatest gain (4.01 ± 0.44 mm). Autologous bone has been considered the gold standard due to its osteoinductive, osteogenic, and osteoconductive capacity. 43 However, its resorption is substantial during the first periods of integration, especially if the bone is of endochondral origin. 44 Hence, depending on the origin, the graft will exhibit a different remodeling pattern. On the other hand, allografts yielded a comparatively lesser bone gain of 1.99 ± 0.37 mm. These findings are consistent with those of other studies 45 where greater peri-implant resorption was observed in those regenerations performed with mineralized freeze-dried bone allograft compared with pristine bone. Two different types of allografts are used in this review: demineralized freeze-dried bone allograft (DFDBA) and mineralized freeze-dried bone allograft (FDBA). However, no significant differences were observed in relation to the bone regeneration achieved. 46 With regard to resorption rates, not only the material used for regeneration but also the type of defect (self-contained or not) must be considered. Along with site morphology, the behavior of graft during the different healing phases could be of clinical interest. In fact, the estimated mean graft resorption after healing in this systematic review was 1.13 ± 0.25 mm after 6 months. Regardless of the technique or the material used, resorption will occur, and thus, it should be anticipated by overcorrecting the defect. Finally, the weighted survival rate was 99.9%, which is similar to the survival rate of implants placed in pristine bone. [47] [48] [49] [50] In a clinical study with a split-mouth design, a survival rate of 100% was reported for implants placed simultaneously with GBR at 5 years of follow-up. 51 Similarly, a systematic review of augmentation procedures reported a survival rate ranging from 93% to 100% after 12 to 60 months of follow-up. 7 No significant differences were found in survival rates between implants placed in regenerated bone or in pristine bone. However, more long-term studies are needed to establish the resorption behavior of regeneration around implants over time.
When analyzing the present results, it is important to bear in mind that the majority of the studies reporting on the utilization of GBR needed minimal bone augmentation for dehiscence or fenestrations, while the studies reporting on the use of block grafts needed more significant bone augmentation for implant placement. Hence, the results from the present investigation, when comparing both techniques, are to be interpreted cautiously since the defects and amount of grafting materials employed differed between them. Also, while the employment of block grafting techniques is usually performed prior to implant placement, GBR procedures are very commonly employed at the time of implant placement. These variables could also play a role in the reported outcomes. On the other hand, collagen barrier membranes could collapse more compared with block grafts due to the lack of rigidity. Also, this could have played a role in the reported outcomes.
While the present report may seem contradictory to the widely reported resorption rate of block grafts and the slow resorption rate of xenografts, several theories could be hypothesized. First, the follow-up periods evaluated are rather short, and more collapse of the block grafts could be expected with longer healing times. As previously mentioned, the characteristics of the defects also influence the outcomes. Also, of paramount importance due to its influence on the reported outcomes is the utilization of xenograft particulate material as well as barrier membranes over the block grafting sites, which could significantly minimize the resorption rate. Similarly, the lack of proper stabilization of the barrier membranes employed for the GBR investigations may have limited the regeneration potential, allowing for mobilization of the site and further graft volume loss.
Horizontal bone regeneration has proven to be a highly predictable technique. Accordingly, studies establishing the type of material offering the best results not only referring to bone quantity but also to bone quality are required. All factors influencing bone remodeling, such as the type of graft and the type of membrane, should also be defined in the future so that clinicians can predict the quantity of biomaterial required for performing bone regeneration. Tissue engineering could also define new materials, avoiding the need for a secondary donor site and offering the same qualitative properties as autologous bone. Several limitations could be described for the present review. First, the type of defect could prejudge the final outcome, and not all horizontal defects have the same regenerative potential. As has been noted before, the heterogeneity of the defect may influence the final results obtained. The type of defect varies among articles, and the potential for regeneration of a bone defect depends not only on the type of biomaterial and surgical technique, but also on its extent and morphology 52 ; therefore, variability of the analyzed defects is an important factor to be taken into account in relation to the results of this study. On the other hand, there are differences between the membranes used, and this might also influence the final outcome. Similarly, consideration is also required on how the measures were made, since in some investigations the measures were taken directly from the bone crest, [22] [23] [24] [25] [26] [28] [29] [30] [33] [34] [35] [36] [37] while in other articles they were taken from the cone beam computed tomography images. 1, 20, 21, 27, 31, 32, 35 Also, the number of articles evaluated greatly differ in between procedures, with 16 investigations included for GBR [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] and only 3 for block grafts. 20, 27, 28 This difference might have also influenced the final result. Lastly, only two articles reported on complications, 22, 24 with most of them being wound infections and membrane exposure. Nonetheless, block grafting procedures are always at higher risk due to the secondary surgical site needed and present with significantly more patient morbidity.
CONCLUSIONS
Within the limitations of this investigation, it can be concluded that no differences in mean bone gain were found among the regenerative techniques analyzed in this review. Block grafts seemed to maintain the volume of the initial augmentation site more than GBR techniques; on the other hand, AG, ALL, and XE were associated with inferior bone gain compared with AG + XE. Regardless of the material used for bone regeneration, graft resorption will occur; consequently, overcorrection of the defect should be performed to compensate for this resorption. Nonetheless, owing to the heterogeneity of the studies, the results presented should be used with caution. In addition, a high survival rate was observed regardless of the biomaterials used for bone augmentation. Long-term results with more than 12 months of follow-up are needed.
